[TNGX] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
07-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 19.51%
YoY- 16.69%
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
Revenue 19,875 14,598 5,771 18,153 5,064 40.71%
PBT -25,486 -20,646 -24,855 -4,514 -8,392 31.98%
Tax 65 64 3 -21 0 -
NP -25,551 -20,710 -24,858 -4,493 -8,392 32.06%
Tax Rate - - - - - -
Total Cost 45,426 35,308 30,629 22,646 13,456 35.52%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
NP Margin -128.56 -141.87 -430.74 -24.75 -165.72 -6.14%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
EPS -0.24 -0.23 -0.28 -0.05 -0.75 -24.77%
EPS Diluted -0.24 -0.23 -0.28 -0.05 -0.75 -24.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.